FERAGALLI, Beatrice
 Distribuzione geografica
Continente #
NA - Nord America 5.748
AS - Asia 4.081
EU - Europa 3.407
SA - Sud America 674
OC - Oceania 56
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 14.029
Nazione #
US - Stati Uniti d'America 5.622
SG - Singapore 1.729
CN - Cina 975
IT - Italia 577
IE - Irlanda 563
BR - Brasile 552
RU - Federazione Russa 415
UA - Ucraina 396
VN - Vietnam 374
SE - Svezia 366
TR - Turchia 340
GB - Regno Unito 287
DE - Germania 234
FR - Francia 185
IN - India 167
HK - Hong Kong 143
FI - Finlandia 70
CA - Canada 62
ES - Italia 58
AU - Australia 53
AR - Argentina 48
JP - Giappone 42
AT - Austria 41
BD - Bangladesh 39
NL - Olanda 39
PL - Polonia 37
BE - Belgio 36
ID - Indonesia 36
MX - Messico 35
TW - Taiwan 29
IR - Iran 27
PT - Portogallo 27
TH - Thailandia 27
EC - Ecuador 26
IQ - Iraq 25
KR - Corea 23
MY - Malesia 23
ZA - Sudafrica 21
CZ - Repubblica Ceca 15
PK - Pakistan 15
CO - Colombia 13
CH - Svizzera 12
CL - Cile 10
RO - Romania 10
PY - Paraguay 9
EU - Europa 7
JO - Giordania 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
IL - Israele 6
JM - Giamaica 6
LT - Lituania 6
MA - Marocco 6
PA - Panama 6
PH - Filippine 6
SA - Arabia Saudita 6
VE - Venezuela 6
HR - Croazia 5
NI - Nicaragua 5
UY - Uruguay 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EE - Estonia 4
EG - Egitto 4
BO - Bolivia 3
GR - Grecia 3
KE - Kenya 3
KZ - Kazakistan 3
LU - Lussemburgo 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AO - Angola 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
KW - Kuwait 2
ME - Montenegro 2
MM - Myanmar 2
NG - Nigeria 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
SC - Seychelles 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BB - Barbados 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
Totale 14.018
Città #
Singapore 1.213
Chandler 660
Jacksonville 577
San Jose 575
Dublin 547
Ashburn 351
Princeton 255
Dallas 247
Beijing 231
Santa Clara 177
Izmir 166
Nanjing 165
Los Angeles 144
Ho Chi Minh City 142
Southend 127
Hong Kong 121
Wilmington 117
Council Bluffs 110
New York 109
Altamura 104
The Dalles 103
Hanoi 93
Cambridge 83
Ann Arbor 74
Dearborn 67
Nanchang 60
Chieti 56
Redondo Beach 49
Boardman 48
Orem 43
Moscow 40
São Paulo 40
Tongling 37
Buffalo 36
Milan 36
Kunming 33
Munich 33
Tokyo 33
Catania 31
Frankfurt am Main 31
Shenyang 31
Seattle 30
Hebei 29
Chennai 28
Menlo Park 26
Denver 25
Tianjin 25
Falls Church 24
Brussels 22
Houston 22
Sydney 22
Washington 22
Woodbridge 22
Jiaxing 21
Rio de Janeiro 21
Toronto 21
Amsterdam 20
Warsaw 20
Atlanta 19
London 19
Santa Pola 19
Vienna 19
Boston 18
Brooklyn 18
Da Nang 18
Hangzhou 18
Istanbul 18
Kuala Lumpur 17
Norwalk 17
Manchester 16
Mumbai 15
Pescara 15
Shanghai 15
Taichung 15
Changsha 14
Chicago 14
Curitiba 14
Helsinki 14
Johannesburg 14
Phoenix 14
Rome 14
Haiphong 13
Montreal 13
Nuremberg 13
San Francisco 13
Stoke-on-Trent 13
Calpe 12
Guangzhou 12
Taipei 12
Lanzhou 11
Naples 11
Poplar 11
Pune 11
Stockholm 11
Ankara 10
Bangkok 10
Columbus 10
Mexico City 10
Bengaluru 9
Guayaquil 9
Totale 8.183
Nome #
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 479
Effects of different doses of Pycnogenol® on plasma oxidative stress: A pilot, supplement study 231
Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections 210
Cone beam computed tomography for dental and maxillofacial imaging: technique improvement and low-dose protocols 209
Effects of collagen remodulation with Centella asiatica (Centellicum®) in Dupuytren palmar fibromatosis: a pilot supplement study 192
[Possibility of false negative results in the diagnosis of lung neoplasms with computerized tomography] 184
Pulmonary nodule [Il nodulo polmonare] 173
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 169
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 160
Biomechanical aspects in late implant failures: Scanning electron microscopy analysis of four clinical cases 156
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 156
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 156
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 150
Mononucleosis-related fatigue: supplementary management with Robuvit®. 144
Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events 142
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 140
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 140
Moderate, diffuse, somatic muscular pain: Effects of supplementation with a Pycnogenol patch 139
Supplementation with a new food grade delivery system of Boswellia and Centella in the intervertebral discs registry: The Sager study 139
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 137
Anatomical features of cephalothoracopagus variations: CT and MRI. 134
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 134
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 133
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 133
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 132
Management of symptoms, pain and mobility with supplementary managements (including Movardol Forte) in osteoarthrosis: A 6-month, morphology supplement study 132
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 131
Valutazione dell'area valvolare aortica (AVA): confronto fra risonanza cardiaca (RCM), ecocardiografiatranstoracia (ETT) e transesofagea (ETE) 130
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 130
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 129
Exploring the concept of vigor and dys-vigor in men of 50-65 years: effects of Robuvit® 129
Assessment of aortic valve area (AVA) by cardiac magnetic resonance (CMR) imaging in comparison with transthoracic (TTE) and transesophageal echocardiography (TEE) 128
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol (R) 128
Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques; 3-year prevention with the supplementation with Pycnogenol®+Centellicum® 128
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 127
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 127
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 126
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 124
Ecografia toracica. Diagnosi e tecniche interventistiche 122
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 121
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 121
Pycnogenol® supplementation in minimal cognitive dysfunction 121
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 120
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 119
Malignant pleural disease 119
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 119
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 118
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 118
Robuvit®: improvement of fatigue in medical convalescence. 116
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 115
Chronic venous insufficiency and venous microangiopathy: Management with compression and Pycnogenol® 115
Improvement of common cold with Pycnogenol®: a Winter registry study. 114
7T mMR in the assessment of acute arterial mesenteric ischemia in a rat model 114
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 114
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 114
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 111
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 110
Small-Bowel Neoplasms: Role of MRI Enteroclysis 110
Primary benign back pain: supplementation with Pycnogenol® 110
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 109
Radiographic evaluation of mediastinal lines as a diagnostic approach to occult or subtle mediastinal abnormalities. 109
Errors in imaging of traumatic injuries 109
Central Cardiovascular Calcifications: Supplementation With Pycnogenol® and Centellicum®: Variations Over 12 Months 109
Anthocran® Phytosome®: Prevention of Recurring Urinary Infections and Symptoms after Catheterization 109
Oxidative stress following administration of levothyroxine in subjects suffering from primary hypothyroidism. 108
Non-small cell lung carcinoma. Early diagnosis: applicability of a screening 108
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 107
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 106
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study 106
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 105
Pulmonary nodule. 104
Supplementation with Robuvit® in subjects with burnout associated to high oxidative stress 104
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 103
Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry 103
A sport cream (Harpago-Boswellia-ginger-escin) for localized neck/shoulder pain 102
Xerostomia: prevention with Pycnogenol® supplementation: a pilot study. 101
PycnoRacer®, a fitness drink including Pycnogenol®, improves recovery and training in the Cooper test 101
Thrombo-prophylaxis prevents thrombotic events in home-managed COVID patients. A registry study 101
Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study 100
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. 99
Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. 99
Malignant pleural disease 99
Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide 99
Assessment of ultrasound acoustic artifacts in patients with acute dyspnea: a multicenter study 98
Pycnogenol®-Centellicum® supplementation improves lung fibrosis and Post-Covid-19 lung healing 97
Transthoracic ultrasound in the assessment of pleural and pulmonary diseases: Use and limitations 96
Pycnogenol® prevents oxidative stress and side effects in patients with hypothyroidism during levothyroxine treatment 96
Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation. 95
Supplementation with Robuvit® in post-mastectomy post-radiation arm lymphedema. 94
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 93
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 93
Thoracic ultrasound in children: evidence and drawbacks 93
Prevalence of Ponticulus Posticus and Migraine in 220 Orthodontic Patients: A Cross-Sectional Study 92
Pleural disease 91
Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study 90
Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study 90
Ocular and optic nerve ischemia: recognition and treatment with intravenous prostaglandin E1. 89
Pycnogenol® supplementation improves cognitive function, attention and mental performance in students.SourceIrvine3 Labs, Department of Biomedical Sciences Chieti - Pescara University, Pescara, Italy. 89
Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol® 88
Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study. 87
Totale 12.453
Categoria #
all - tutte 56.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 0 30
2021/2022664 25 19 10 102 75 38 20 49 37 22 73 194
2022/20231.889 182 272 93 201 165 360 116 155 210 25 74 36
2023/20241.020 57 40 75 34 58 227 252 54 43 58 34 88
2024/20252.625 164 535 420 76 102 103 47 142 358 139 216 323
2025/20264.945 329 181 571 742 460 294 714 348 525 423 290 68
Totale 14.602